Oral tolerance with Copolymer 1 for the treatment of multiple sclerosis
AUTOR(ES)
Weiner, Howard L.
FONTE
The National Academy of Sciences
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=34268Documentos Relacionados
- Developing Therapeutics for the Treatment of Multiple Sclerosis
- Low dose oral methotrexate treatment of multiple sclerosis: a pilot study.
- The treatment of chronic progressive multiple sclerosis with cladribine.
- Long-term treatment of multiple sclerosis with azathioprine
- Expression of Urokinase Plasminogen Activator Receptor on Monocytes from Patients with Relapsing-Remitting Multiple Sclerosis: Effect of Glatiramer Acetate (Copolymer 1)